Ophthalmology Times: The 2025 EURETINA meeting was a held in Paris, France this year and was a testament to the advancments that have been made in research, diagnosis, and treatment. As the 2025 ...

Justis Ehlers, MD, spoke with Ophthalmology Times to share key findings from his recent presentation at the 2025 Retina Soceity meeting, which was held in Chicago, Illinois.

The study included 1,466 patients with newly diagnosed POAG receiving care at health systems in the Sight Outcomes Research ...

Discover new insights into central serous chorioretinopathy, including pathophysiology, imaging techniques, and effective treatment options for better patient outcomes.

Character Biosciences enhances its leadership team and secures $93 million in Series B funding to advance treatments for ...

Optos partners with Toku to integrate BioAge AI into retinal imaging devices, enhancing eye care professionals' insights into ...

Guymer discusses early intervention strategies for intermediate AMD, highlighting risk factors, and potential trial designs ...

iVeena Delivery Systems has been awarded a $2 million phase 2 Small Business Innovation Research (SBIR) grant from the ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

We ask leading experts in the field what eye disease they would cure and why. In celebration of Ophthalmology Times' 50th ...

A new staging system for diabetic retinopathy and macular edema is essential, integrating advanced imaging techniques for better disease management and patient outcomes.